{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T09:48:08Z","timestamp":1780998488126,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,1]]},"DOI":"10.7759\/cureus.23731","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T13:10:48Z","timestamp":1648818648000},"source":"Crossref","is-referenced-by-count":2,"title":["Comparative Analysis of Inhaled Insulin With Other Types in Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Abu baker","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aftab","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Gul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazrat","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syeda","family":"Laiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umer Khayaam","family":"Orakzai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2013.11.005","article-title":"Diabetes in the young - a global view and worldwide estimates of numbers of children with type 1 diabetes","volume":"103","author":"Patterson C","year":"2014","unstructured":"Patterson C, Guariguata L, Dahlquist G, Solt\u00e9sz G, Ogle G, Silink M. Diabetes in the young - a global view and worldwide estimates of numbers of children with type 1 diabetes. Diabetes Res Clin Pract. 2014, 103:161-75. 10.1016\/j.diabres.2013.11.005","journal-title":"Diabetes Res Clin Pract"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-S062","article-title":"Diagnosis and classification of diabetes mellitus","volume":"32 Suppl 1","author":"American Diabetes Association","year":"2009","unstructured":"American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2009, 32 Suppl 1:S62-7. 10.2337\/dc09-S062","journal-title":"Diabetes Care"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.060244","article-title":"Type 1 diabetes: pathogenesis and prevention","volume":"175","author":"Gillespie KM","year":"2006","unstructured":"Gillespie KM. Type 1 diabetes: pathogenesis and prevention. CMAJ. 2006, 175:165-70. 10.1503\/cmaj.060244","journal-title":"CMAJ"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/pl00002958","article-title":"Geographical variation of presentation at diagnosis of type I diabetes in children: the EURODIAB study. European and Dibetes","volume":"44 Suppl 3","author":"L\u00e9vy-Marchal C","year":"2001","unstructured":"L\u00e9vy-Marchal C, Patterson CC, Green A. Geographical variation of presentation at diagnosis of type I diabetes in children: the EURODIAB study. European and Dibetes. Diabetologia. 2001, 44 Suppl 3:B75-80. 10.1007\/pl00002958","journal-title":"Diabetologia"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k1497","article-title":"Prevalence of diagnosed type 1 and type 2 diabetes among US adults in 2016 and 2017: population based study","volume":"362","author":"Xu G","year":"2018","unstructured":"Xu G, Liu B, Sun Y, Du Y, Snetselaar LG, Hu FB, Bao W. Prevalence of diagnosed type 1 and type 2 diabetes among US adults in 2016 and 2017: population based study. BMJ. 2018, 362:k1497. 10.1136\/bmj.k1497","journal-title":"BMJ"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31320-5","article-title":"Type 1 diabetes","volume":"391","author":"DiMeglio LA","year":"2018","unstructured":"DiMeglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. Lancet. 2018, 391:2449-62. 10.1016\/S0140-6736(18)31320-5","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.49.12.2142","article-title":"Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro","volume":"49","author":"Lepore M","year":"2000","unstructured":"Lepore M, Pampanelli S, Fanelli C, et al.. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes. 2000, 49:2142-8. 10.2337\/diabetes.49.12.2142","journal-title":"Diabetes"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2012.01580.x","article-title":"The pharmacokinetics and pharmacodynamics of rapid-acting insulin analogues and their clinical consequences","volume":"14","author":"Home PD","year":"2012","unstructured":"Home PD. The pharmacokinetics and pharmacodynamics of rapid-acting insulin analogues and their clinical consequences. Diabetes Obes Metab. 2012, 14:780-8. 10.1111\/j.1463-1326.2012.01580.x","journal-title":"Diabetes Obes Metab"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2009.01039.x","article-title":"Pharmacokinetics and linear exposure of AFRESA compared with the subcutaneous injection of regular human insulin","volume":"11","author":"Rave K","year":"2009","unstructured":"Rave K, Potocka E, Heinemann L, et al.. Pharmacokinetics and linear exposure of AFRESA compared with the subcutaneous injection of regular human insulin. Diabetes Obes Metab. 2009, 11:715-20. 10.1111\/j.1463-1326.2009.01039.x","journal-title":"Diabetes Obes Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1089\/152091502320798204","article-title":"Technosphere\/insulin--a new approach for effective delivery of human insulin via the pulmonary route","volume":"4","author":"Pf\u00fctzner A","year":"2002","unstructured":"Pf\u00fctzner A, Mann AE, Steiner SS. Technosphere\/insulin--a new approach for effective delivery of human insulin via the pulmonary route. Diabetes Technol Ther. 2002, 4:589-94. 10.1089\/152091502320798204","journal-title":"Diabetes Technol Ther"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton B","year":"2015","unstructured":"Hutton B, Salanti G, Caldwell DM, et al.. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015, 162:777-84. 10.7326\/M14-2385","journal-title":"Ann Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins JP","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003, 327:557-60. 10.1136\/bmj.327.7414.557","journal-title":"BMJ"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(00)03638-2","article-title":"Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study","volume":"357","author":"Skyler JS","year":"2001","unstructured":"Skyler JS, Cefalu WT, Kourides IA, Landschulz WH, Balagtas CC, Cheng SL, Gelfand RA. Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study. Lancet (london, england. 2001, 357:331-335. 10.1016\/s0140-6736(00)03638-2","journal-title":"Lancet (london, england"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.11.2622","article-title":"Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial","volume":"27","author":"Quattrin T","year":"2004","unstructured":"Quattrin T, B\u00e9langer A, Bohannon NJ, Schwartz SL. Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial. Diabetes Care. 2004, 27:2622-7. 10.2337\/diacare.27.11.2622","journal-title":"Diabetes Care"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.7.1630","article-title":"Use of inhaled insulin in a basal\/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial","volume":"28","author":"Skyler JS","year":"2005","unstructured":"Skyler JS, Weinstock RS, Raskin P, Yale JF, Barrett E, Gerich JE, Gerstein HC. Use of inhaled insulin in a basal\/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial. Diabetes Care. 2005, 28:1630-5. 10.2337\/diacare.28.7.1630","journal-title":"Diabetes Care"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-006-0161-3","article-title":"Efficacy and safety of preprandial human insulin inhalation powder versus injectable insulin in patients with type 1 diabetes","volume":"49","author":"Garg S","year":"2006","unstructured":"Garg S, Rosenstock J, Silverman BL, Sun B, Konkoy CS, de la Pe\u00f1a A, Muchmore DB. Efficacy and safety of preprandial human insulin inhalation powder versus injectable insulin in patients with type 1 diabetes. Diabetologia. 2006, 49:891-9. 10.1007\/s00125-006-0161-3","journal-title":"Diabetologia"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-1863","article-title":"Two-year safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 1 diabetes","volume":"30","author":"Skyler JS","year":"2007","unstructured":"Skyler JS, Jovanovic L, Klioze S, Reis J, Duggan W. Two-year safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 1 diabetes. Diabetes Care. 2007, 30:579-85. 10.2337\/dc06-1863","journal-title":"Diabetes Care"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2008.08.008","article-title":"Safety and efficacy of inhaled human insulin (Exubera) during discontinuation and readministration of therapy in adults with type 1 diabetes: A 3-year randomized controlled trial","volume":"82","author":"Skyler JS","year":"2008","unstructured":"Skyler JS, Hollander PA, Jovanovic L, et al.. Safety and efficacy of inhaled human insulin (Exubera) during discontinuation and readministration of therapy in adults with type 1 diabetes: A 3-year randomized controlled trial. Diabetes Res Clin Pract. 2008, 82:238-46. 10.1016\/j.diabres.2008.08.008","journal-title":"Diabetes Res Clin Pract"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2008-210610","article-title":"Efficacy and Safety of Inhaled Human Insulin (Exu hera\u00ae) Compared to Subcutaneous Insulin in Children Ages 6 to 11 Years with Type 1 Diabetes Mellitus: Results of a 3-Month, Randomized, Parallel Trial","volume":"21","author":"White NH","year":"2020","unstructured":"White NH, Quattrin T, Aubin LB, Duggan WT, England RD, Fryburg JS. Efficacy and Safety of Inhaled Human Insulin (Exu hera\u00ae) Compared to Subcutaneous Insulin in Children Ages 6 to 11 Years with Type 1 Diabetes Mellitus: Results of a 3-Month, Randomized, Parallel Trial. J Pediatr Endocrinol Metab. 2020, 21:555-68. 10.1515\/jpem-2008-210610","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2009.0041","article-title":"Efficacy and safety of AIR inhaled insulin compared to insulin lispro in patients with type 1 diabetes mellitus in a 6-month, randomized, noninferiority trial","volume":"11 Suppl 2","author":"Comulada AL","year":"2009","unstructured":"Comulada AL, Renard E, Nakano M, Rais N, Mao X, Webb DM, Milicevic Z. Efficacy and safety of AIR inhaled insulin compared to insulin lispro in patients with type 1 diabetes mellitus in a 6-month, randomized, noninferiority trial. Diabetes Technol Ther. 2009, 11 Suppl 2:S17-25. 10.1089\/dia.2009.0041","journal-title":"Diabetes Technol Ther"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2009.0040","article-title":"Two-year efficacy and safety of AIR inhaled insulin in patients with type 1 diabetes: An open-label randomized controlled trial","volume":"11 Suppl 2","author":"Garg SK","year":"2009","unstructured":"Garg SK, Mathieu C, Rais N, et al.. Two-year efficacy and safety of AIR inhaled insulin in patients with type 1 diabetes: An open-label randomized controlled trial. Diabetes Technol Ther. 2009, 11 Suppl 2:S5-S16. 10.1089\/dia.2009.0040","journal-title":"Diabetes Technol Ther"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2008.02654.x","article-title":"Safety and efficacy of inhaled insulin (AERx iDMS) compared with subcutaneous insulin therapy in patients with Type 1 diabetes: 1-year data from a randomized, parallel group trial","volume":"26","author":"Moses RG","year":"2009","unstructured":"Moses RG, Bartley P, Lunt H, et al.. Safety and efficacy of inhaled insulin (AERx iDMS) compared with subcutaneous insulin therapy in patients with Type 1 diabetes: 1-year data from a randomized, parallel group trial. Diabet Med. 2009, 26:260-7. 10.1111\/j.1464-5491.2008.02654.x","journal-title":"Diabet Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-0075","article-title":"Inhaled technosphere insulin compared with injected prandial insulin in type 1 diabetes: a randomized 24-week trial","volume":"38","author":"Bode BW","year":"2015","unstructured":"Bode BW, McGill JB, Lorber DL, Gross JL, Chang PC, Bregman DB. Inhaled technosphere insulin compared with injected prandial insulin in type 1 diabetes: a randomized 24-week trial. Diabetes Care. 2015, 38:2266-73. 10.2337\/dc15-0075","journal-title":"Diabetes Care"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14202","article-title":"Hypoglycaemia is reduced with use of inhaled Technosphere\u00ae Insulin relative to insulin aspart in type 1 diabetes mellitus","volume":"37","author":"Seaquist ER","year":"2020","unstructured":"Seaquist ER, Blonde L, McGill JB, et al.. Hypoglycaemia is reduced with use of inhaled Technosphere\u00ae Insulin relative to insulin aspart in type 1 diabetes mellitus. Diabet Med. 2020, 37:752-9. 10.1111\/dme.14202","journal-title":"Diabet Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.13099","article-title":"Understanding inhaled technosphere insulin: results of an early randomized trial in type 1 diabetes mellitus","volume":"13","author":"McGill JB","year":"2021","unstructured":"McGill JB, Weiss D, Grant M, Jones MC, Kendall DM, Hoogwerf BJ. Understanding inhaled technosphere insulin: results of an early randomized trial in type 1 diabetes mellitus. J Diabetes. 2021, 13:164-72. 10.1111\/1753-0407.13099","journal-title":"J Diabetes"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-145-9-200611070-00009","article-title":"Meta-analysis: efficacy and safety of inhaled insulin therapy in adults with diabetes mellitus","volume":"145","author":"Ceglia L","year":"2006","unstructured":"Ceglia L, Lau J, Pittas AG. Meta-analysis: efficacy and safety of inhaled insulin therapy in adults with diabetes mellitus. Ann Intern Med. 2006, 145:665-75. 10.7326\/0003-4819-145-9-200611070-00009","journal-title":"Ann Intern Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(15)00280-6","article-title":"Efficacy, safety, and patient acceptability of Technosphere inhaled insulin for people with diabetes: a systematic review and meta-analysis","volume":"3","author":"Pittas AG","year":"2015","unstructured":"Pittas AG, Westcott GP, Balk EM. Efficacy, safety, and patient acceptability of Technosphere inhaled insulin for people with diabetes: a systematic review and meta-analysis. LANCET DIABETES ENDO. 2015, 3:886-894. 10.1016\/s2213-8587(15)00280-6","journal-title":"LANCET DIABETES ENDO"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1177\/193229680800200325","article-title":"The failure of exubera: are we beating a dead horse?","volume":"2","author":"Heinemann L","year":"2008","unstructured":"Heinemann L. The failure of exubera: are we beating a dead horse?. J Diabetes Sci Technol. 2008, 2:518-29. 10.1177\/193229680800200325","journal-title":"J Diabetes Sci Technol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2016.1121230","article-title":"Technosphere insulin: inhaled prandial insulin","volume":"16","author":"Setji TL","year":"2016","unstructured":"Setji TL, Hong BD, Feinglos MN. Technosphere insulin: inhaled prandial insulin. Expert Opin Biol Ther. 2016, 16:111-7. 10.1517\/14712598.2016.1121230","journal-title":"Expert Opin Biol Ther"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15197","article-title":"Cough as an adverse effect on inhalation pharmaceutical products","volume":"177","author":"Chang RY","year":"2020","unstructured":"Chang RY, Kwok PC, Ghassabian S, Brannan JD, Koskela HO, Chan HK. Cough as an adverse effect on inhalation pharmaceutical products. Br J Pharmacol. 2020, 177:4096-112. 10.1111\/bph.15197","journal-title":"Br J Pharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/91195-comparative-analysis-of-inhaled-insulin-with-other-types-in-type-1-diabetes-mellitus-a-systematic-review-and-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:36:44Z","timestamp":1707507404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/91195-comparative-analysis-of-inhaled-insulin-with-other-types-in-type-1-diabetes-mellitus-a-systematic-review-and-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.23731","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,1]]}}}